132 related articles for article (PubMed ID: 9494919)
1. Perinatal outcomes in a prospective matched pair study of pregnancy and unexplained elevated or low AFP screening.
Cho S; Durfee KK; Keel BA; Parks LH
J Perinat Med; 1997; 25(6):476-83. PubMed ID: 9494919
[TBL] [Abstract][Full Text] [Related]
2. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
Cusick W; Rodis JF; Vintzileos AM; Albini SM; McMahon M; Campbell WA
J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757
[TBL] [Abstract][Full Text] [Related]
3. Unexplained elevated maternal serum alpha-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes.
Chandra S; Scott H; Dodds L; Watts C; Blight C; Van Den Hof M
Am J Obstet Gynecol; 2003 Sep; 189(3):775-81. PubMed ID: 14526312
[TBL] [Abstract][Full Text] [Related]
4. Very low second-trimester maternal serum alpha-fetoprotein: Association with high birth weight.
Baschat AA; Harman CR; Farid G; Chodirker BN; Evans JA
Obstet Gynecol; 2002 Apr; 99(4):531-6. PubMed ID: 12039105
[TBL] [Abstract][Full Text] [Related]
5. Is unexplained elevated maternal serum alpha-fetoprotein still important predictor for adverse pregnancy outcome?
Başbuğ D; Başbuğ A; Gülerman C
Ginekol Pol; 2017; 88(6):325-330. PubMed ID: 28727133
[TBL] [Abstract][Full Text] [Related]
6. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
[TBL] [Abstract][Full Text] [Related]
7. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
8. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death.
Silver RM; Draper ML; Byrne JL; Ashwood EA; Lyon JL; Branch DW
Obstet Gynecol; 1994 Jan; 83(1):150-5. PubMed ID: 7505912
[TBL] [Abstract][Full Text] [Related]
9. Twin pregnancies in the second trimester in women in an alpha-fetoprotein screening program: sonographic evaluation and outcome.
Pretorius DH; Budorick NE; Scioscia AL; Krabbe JK; Ko S; Myhre CM
AJR Am J Roentgenol; 1993 Nov; 161(5):1007-13. PubMed ID: 7506005
[TBL] [Abstract][Full Text] [Related]
10. Unexplained elevations of maternal serum alpha-fetoprotein.
Katz VL; Chescheir NC; Cefalo RC
Obstet Gynecol Surv; 1990 Nov; 45(11):719-26. PubMed ID: 1700347
[TBL] [Abstract][Full Text] [Related]
11. Abnormal levels of maternal serum human chorionic gonadotropin and alpha-fetoprotein in the second trimester: relation to fetal weight and preterm delivery.
Morssink LP; Kornman LH; Beekhuis JR; De Wolf BT; Mantingh A
Prenat Diagn; 1995 Nov; 15(11):1041-6. PubMed ID: 8606883
[TBL] [Abstract][Full Text] [Related]
12. Unexplained elevated maternal serum alpha-fetoprotein levels and pregnancy outcome in twins.
Hong S; Berkowitz G; Wang W; Stone J; Ainbender E
Obstet Gynecol; 1996 Sep; 88(3):337-42. PubMed ID: 8752235
[TBL] [Abstract][Full Text] [Related]
13. Outcome of pregnancy in patients with unexplained elevated or low levels of maternal serum alpha-fetoprotein.
Burton BK
Obstet Gynecol; 1988 Nov; 72(5):709-13. PubMed ID: 2459638
[TBL] [Abstract][Full Text] [Related]
14. The effects on fetal development of high alpha-fetoprotein and maternal smoking.
Heinonen S; Ryynänen M; Kirkinen P
Am J Public Health; 1999 Apr; 89(4):561-3. PubMed ID: 10191802
[TBL] [Abstract][Full Text] [Related]
15. Low birth weight and preterm delivery in relation to early-gestation vaginal bleeding and elevated maternal serum alpha-fetoprotein.
Williams MA; Hickok DE; Zingheim RW; Mittendorf R; Kimelman J; Mahony BS
Obstet Gynecol; 1992 Nov; 80(5):745-9. PubMed ID: 1383900
[TBL] [Abstract][Full Text] [Related]
16. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.
Anfuso S; Soncini E; Bonelli P; Piantelli G; Gramellini D
Acta Biomed; 2007 Dec; 78(3):214-9. PubMed ID: 18330082
[TBL] [Abstract][Full Text] [Related]
17. Elevated maternal serum alpha-fetoprotein: association with placental sonolucencies, fetomaternal hemorrhage, vaginal bleeding, and pregnancy outcome in the absence of fetal anomalies.
Bernstein IM; Barth RA; Miller R; Capeless EL
Obstet Gynecol; 1992 Jan; 79(1):71-4. PubMed ID: 1370124
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of elevated anticardiolipin antibodies in pregnant women with unexplained elevations of alpha-fetoprotein.
Yetman DL; Kutteh WH; Castorena R; Brown C; Baskin L
J Reprod Immunol; 1997 Apr; 33(1):71-81. PubMed ID: 9185078
[TBL] [Abstract][Full Text] [Related]
19. Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome.
Benn PA; Craffey A; Horne D; Ramsdell L; Rodis JF
J Matern Fetal Med; 2000; 9(3):165-9. PubMed ID: 10914624
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein.
Wenstrom KD; Owen J; Davis RO; Brumfield CG
Obstet Gynecol; 1996 Feb; 87(2):213-6. PubMed ID: 8559526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
